Coherus Oncology (CHRS) Capital Expenditures Growth (1y) (2014 - 2025)
Coherus Oncology (CHRS) Capital Expenditures Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Coherus Oncology | 194.37 Mn | 27.32 Mn | 8.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -1,108.50% |
| Mar 31, 2025 | 102.51% |
| Jun 30, 2024 | -40,100.00% |
| Mar 31, 2024 | -123,667.76% |
| Dec 31, 2023 | -60.92% |
| Jun 30, 2023 | -88.64% |
| Mar 31, 2023 | -75.28% |
| Dec 31, 2022 | -81.41% |
| Sep 30, 2022 | 75.10% |
| Jun 30, 2022 | 112.05% |
| Mar 31, 2022 | 324.14% |
| Dec 31, 2021 | -50.84% |
| Sep 30, 2021 | -87.64% |
| Jun 30, 2021 | -82.59% |
| Mar 31, 2021 | -91.87% |
| Dec 31, 2020 | -27.99% |
| Sep 30, 2020 | 12,523.53% |
| Jun 30, 2020 | 1,209.89% |
| Mar 31, 2020 | 432.24% |
| Dec 31, 2019 | 132,100.00% |